Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 6:18 AM UTC
| NCT Number | NCT05894239 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 230 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | June 29, 2026 (2 weeks ago) |
As of July 19, 2026: Clinical trial NCT05894239 is currently recruiting participants. This phase3 study for breast cancer is actively seeking new participants at 20 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05894239 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05894239 was last updated 2 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.